Follow
Kim Lauper-Luong Ba
Kim Lauper-Luong Ba
Rheumatology, HUG, Switzerland & Centre for Epidemiology Versus Arthritis, University of Manchester
Verified email at hcuge.ch
Title
Cited by
Cited by
Year
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ...
Annals of the rheumatic diseases 82 (1), 3-18, 2023
4542023
Global epidemiology of rheumatoid arthritis
A Finckh, B Gilbert, B Hodkinson, SC Bae, R Thomas, KD Deane, ...
Nature Reviews Rheumatology 18 (10), 591-602, 2022
2272022
Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study
N Madelon, K Lauper, G Breville, I Sabater Royo, R Goldstein, DO Andrey, ...
Clinical Infectious Diseases, 2021
114*2021
Cardiovascular risk in patients with rheumatoid arthritis
K Lauper, C Gabay
Seminars in immunopathology 39 (4), 447-459, 2017
712017
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients …
K Lauper, DC Nordström, K Pavelka, MV Hernández, TK Kvien, ...
Annals of the rheumatic diseases 77 (9), 1276-1282, 2018
702018
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
DS Courvoisier, K Chatzidionysiou, D Mongin, K Lauper, X Mariette, ...
Rheumatology 60 (2), 820-828, 2021
652021
Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis
K Lauper, DS Courvoisier, P Chevallier, A Finckh, C Gabay
Arthritis care & research 70 (12), 1756-1763, 2018
632018
Omicron-specific cytotoxic T-cell responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with ocrelizumab
N Madelon, N Heikkilä, IS Royo, P Fontannaz, G Breville, K Lauper, ...
JAMA neurology 79 (4), 399-404, 2022
622022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
GE Fragoulis, E Nikiphorou, M Dey, SS Zhao, DS Courvoisier, L Arnaud, ...
Annals of the rheumatic diseases 82 (6), 742-753, 2023
532023
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’collaboration
K Lauper, M Iudici, D Mongin, SA Bergstra, D Choquette, C Codreanu, ...
Annals of the rheumatic diseases 81 (10), 1358-1366, 2022
512022
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
R Giacomelli, A Afeltra, E Bartoloni, O Berardicurti, M Bombardieri, ...
Autoimmunity Reviews, 102738, 2020
392020
One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals
M Nehme, O Braillard, F Chappuis, DS Courvoisier, L Kaiser, PM Soccal, ...
Journal of Internal Medicine, 2022
322022
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis
D Alpizar-Rodriguez, L Brulhart, RB Mueller, B Möller, J Dudler, A Ciurea, ...
Clinical rheumatology 36 (3), 677-682, 2017
312017
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort …
K Lauper, D Mongin, F Iannone, EK Kristianslund, TK Kvien, ...
Seminars in arthritis and rheumatism 50 (1), 17-24, 2020
262020
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
D Mongin, K Lauper, C Turesson, ML Hetland, EK Kristianslund, TK Kvien, ...
RMD open 5 (2), e000994, 2019
262019
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
K Lauper, D Mongin, F Iannone, EK Kristianslund, TK Kvien, D Nordström, ...
RMD open 4 (2), e000809, 2018
222018
Prevalence of post-COVID condition 12 weeks after Omicron infection compared to negative controls and association with vaccination status
M Nehme, P Vetter, F Chappuis, L Kaiser, I Guessous, O Braillard, F Assal, ...
Clinical Infectious Diseases, 2022
21*2022
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
DS Courvoisier, K Lauper, J Kedra, M De Wit, B Fautrel, T Frisell, ...
Annals of the rheumatic diseases 81 (6), 780-785, 2022
17*2022
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
BTP Gilbert, C Lamacchia, D Mongin, K Lauper, E Trunk, O Studer, ...
BMJ open 11 (7), e048409, 2021
172021
Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients
N Madelon, N Heikkilä, IS Royo, P Fontannaz, G Breville, K Lauper, ...
Medrxiv, 2021
172021
The system can't perform the operation now. Try again later.
Articles 1–20